Transaction DateRecipientSharesTypePriceValue
23rd July 2020William Edward Mc Kechnie110,000Exercise of derivative$0.17$19,030.00
6th May 2020Christopher Bunka200,000Grant/award etc.$0.23$46,000.00
20th December 2019Nicholas W Baxter110,000Exercise of derivative$0.10$11,000.00
15th February 2019Allan Horst Spissinger50,000Exercise of derivative$0.37$18,500.00
Lexaria Bioscience
Lexaria Bioscience logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.


Lexaria Bioscience Corp. engages in the development of strategic partnerships and in the proprietary nutrient infusion technologies for the production of superfoods. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.


Ticker: LXRP
Sector: Consumer Non-Durables
Industry: Food: Major Diversified
SEC Central Index Key (CIK): 1348362
Employees:
Exchange: US OTC
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals